153 related articles for article (PubMed ID: 20584688)
41. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
42. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
43. [Effects of siRNA on expression of livin and dose- and time-response in human malignant melanoma LiBr cells].
Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug; 23(8):741-4. PubMed ID: 17618569
[TBL] [Abstract][Full Text] [Related]
44. [Effects of gene Livin transfection affect on the apoptosis in bladder carcinoma cells].
Liu XK; Liu HB; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):853-5. PubMed ID: 18756993
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical expression of interleukin-4, -6, -8, and -12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinoma.
de Oliveira MV; Fraga CA; Gomez RS; Paula AM
Head Neck; 2009 Nov; 31(11):1439-46. PubMed ID: 19424975
[TBL] [Abstract][Full Text] [Related]
46. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
[TBL] [Abstract][Full Text] [Related]
47. Maspin expression in oral squamous cell carcinoma.
Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis.
Ohba S; Fujii H; Ito S; Fujimaki M; Matsumoto F; Furukawa M; Yokoyama J; Kusunoki T; Ikeda K; Hino O
J Oral Pathol Med; 2010 Jan; 39(1):74-8. PubMed ID: 19709351
[TBL] [Abstract][Full Text] [Related]
49. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
[TBL] [Abstract][Full Text] [Related]
50. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
51. [The TP53 and RPS6 alterations at the invasive tumor front, center and stroma of oral squamous cell carcinoma].
Wang XH; Fan MW; Sun ZJ; Chen XM; Wang L; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Mar; 42(3):140-3. PubMed ID: 17565818
[TBL] [Abstract][Full Text] [Related]
52. A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas.
Søland TM; Husvik C; Koppang HS; Boysen M; Sandvik L; Clausen OP; Christoffersen T; Bryne M
J Oral Pathol Med; 2008 Oct; 37(9):535-42. PubMed ID: 18284542
[TBL] [Abstract][Full Text] [Related]
53. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
[TBL] [Abstract][Full Text] [Related]
54. Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study.
Cavicchioli Buim ME; Gurgel CA; Gonçalves Ramos EA; Lourenço SV; Soares FA
Hum Pathol; 2011 Oct; 42(10):1484-90. PubMed ID: 21496866
[TBL] [Abstract][Full Text] [Related]
55. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
Liang X; Mao Z; He Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
[TBL] [Abstract][Full Text] [Related]
56. [Gene transfection of Livin isoforms into A549 cell line and its effect on cell growth and sensitivity to chemotherapy and radiotherapy].
Sun JG; Liao RX; Chen ZT; Wang ZX; Zhang Q; Hu YD; Wang DL
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):836-40. PubMed ID: 16409786
[TBL] [Abstract][Full Text] [Related]
57. [Expression of Livin mRNA and protein in human oral squamous cell carcinoma].
Zong ZH; Shang DH; Sun CF
Shanghai Kou Qiang Yi Xue; 2007 Jun; 16(3):315-8. PubMed ID: 17660923
[TBL] [Abstract][Full Text] [Related]
58. Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas.
Tosco P; La Terra Maggiore GM; Forni P; Berrone S; Chiusa L; Garzino-Demo P
Oral Dis; 2011 Jan; 17(1):102-8. PubMed ID: 20659261
[TBL] [Abstract][Full Text] [Related]
59. Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma.
Wang X; Fan M; Chen X; Wang S; Alsharif MJ; Wang L; Liu L; Deng H
Oral Oncol; 2006 Aug; 42(7):740-4. PubMed ID: 16455286
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
